芩暴红止咳口服液对支气管肺炎炎症因子水平的影响

Efficacy of the Qinbaohong Zhike oral liquid on inflammatory factors in patients with bronchopneumonia

目的:观察芩暴红止咳口服液辅助治疗支气管肺炎的临床效果。方法:120例支气管肺炎患者随机分为对照组与观察组,对照组采用常规治疗,观察组在对照组的基础上加用芩暴红止咳口服液治疗,比较两组的治疗效果,主要临床症状、体征改善情况及炎症因子改善情况。结果:治疗2周后比较,观察组总有效率高于对照组,P<0.05。观察组退热时间、止咳时间、止喘时间、肺部啰音消失时间均显著早于对照组,P<0.05。治疗2周后,两组血清白细胞介素-6(Interleukin-6,IL-6)、C反应蛋白(C-reactive Protein,CRP)、肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)水平比较,观察组低于对照组,P<0.05。结论:采用芩暴红止咳口服液辅助治疗支气管肺炎可显著提高治疗效果,改善临床症状,减轻炎症程度,值得临床推广应用。

Objective:To observe the clinical effect of the Qinbaohongzhike oral liquid(芩暴红止咳口服液)on bronchopneumonia.Methods:120 patients with bronchopneumonia were randomly divided into the control group and the observation group.The control group was treated by conventional treatment.The observation group was treated with the Qinbaohongzhike oral liquid more.Results:Efficiency in the observation group was higher than the control group,P<0.05.The fever reduction time,cough relief time,asthma relief time,and disappearance of lung rales in the observation group were significantly earlier than those in the control group,P<0.05.After 2 weeks of treatment,the levels of serum IL-6,CRP,and TNF-αin the observation group were lower than the control group,P<0.05.Conclusion:The Qinbaohongzhike oral liquid can significantly improve the therapeutic effect,improve clinical symptoms,and reduce the degree of inflammation,which is worthy of clinical application.